Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.4050 (-1.12%) ($8.4050 - $8.4050) on Thu. May. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 66 | Latest Price | $8.4050(-1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(29%) XLRE(28%) SDY(26%) CEMB(25%) XAR(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.725% in a week (0% probabilities). VIXM(-26%) VXX(-24%) TLT(-16%) VCIT(-12%) LQD(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.49(-1%) | 10 Day Moving Average | $8.51(-1.23%) | 20 Day Moving Average | $8.12(3.51%) | To recent high | -12.8% | To recent low | 14% | Market Cap | $1.483b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |